Celastrol enhances TRAIL-induced apoptosis in human glioblastoma via the death receptor pathway
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Celastrol enhances TRAIL-induced apoptosis in human glioblastoma via the death receptor pathway
Authors
Keywords
Celastrol, TRAIL, U87-MG, DR5, Apoptosis
Journal
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-07-08
DOI
10.1007/s00280-019-03900-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Glioblastoma and chemoresistance to alkylating agents: Involvement of apoptosis, autophagy, and unfolded protein response
- (2018) Sabine Hombach-Klonisch et al. PHARMACOLOGY & THERAPEUTICS
- A Mechanistic Overview of Triptolide and Celastrol, Natural Products from Tripterygium wilfordii Hook F
- (2018) Shao-Ru Chen et al. Frontiers in Pharmacology
- A new mechanism of inhibition of IL-1β secretion by celastrol through the NLRP3 inflammasome pathway
- (2017) Wenyu Xin et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- DATS sensitizes glioma cells to TRAIL-mediated apoptosis by up-regulation of death receptor 5 via ROS
- (2017) Jung Soon Hwang et al. FOOD AND CHEMICAL TOXICOLOGY
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- Intracellular localization of DR5 and related regulatory pathways as a mechanism of resistance to TRAIL in cancer
- (2016) Ufuk Mert et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Celastrol ameliorates experimental colitis in IL-10 deficient mice via the up-regulation of autophagy
- (2015) Jie Zhao et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Celastrol induces apoptosis and autophagy via the ROS/JNK signaling pathway in human osteosarcoma cells: an in vitro and in vivo study
- (2015) H-Y Li et al. Cell Death & Disease
- Evodiamine sensitizes U87 glioblastoma cells to TRAIL via the death receptor pathway
- (2014) MUHAMMAD KHAN et al. Molecular Medicine Reports
- Celastrol targets proteostasis and acts synergistically with a heat-shock protein 90 inhibitor to kill human glioblastoma cells
- (2014) S Boridy et al. Cell Death & Disease
- Celastrol inhibits growth and induces apoptotic cell death in melanoma cells via the activation ROS-dependent mitochondrial pathway and the suppression of PI3K/AKT signaling
- (2012) Ju-Hye Lee et al. APOPTOSIS
- Up-regulation of death receptor 4 and 5 by celastrol enhances the anti-cancer activity of TRAIL/Apo-2L
- (2010) Hong Zhu et al. CANCER LETTERS
- Naringenin up-regulates the expression of death receptor 5 and enhances TRAIL-induced apoptosis in human lung cancer A549 cells
- (2010) Cheng-Yun Jin et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Synergistic Anti-Cancer Activity by the Combination of TRAIL/APO-2L and Celastrol
- (2009) Hong Zhu et al. CANCER INVESTIGATION
- Two hour exposure to sodium butyrate sensitizes bladder cancer to anticancer drugs
- (2008) Degui Wang et al. INTERNATIONAL JOURNAL OF UROLOGY
- Quercetin promotes degradation of survivin and thereby enhances death-receptor–mediated apoptosis in glioma cells
- (2008) Markus D. Siegelin et al. NEURO-ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started